Story Summary: ISB has engaged Complete Genomics to sequence 100 genomes, the majority of which will be used to investigate this disease, with samples from affected individuals, family members, and matched controls to study modifiers of disease presentation and progression. This will be the largest complete human genome disease association study conducted to date, and will be the first 100-genome study produced by Complete Genomics newly expanded sequencing facility. ISB President Dr. Leroy Hood said, We were pleased with the quality of the raw sequencing data and variations reports that Complete Genomics generated for our four-genome pilot project earlier this year. The Society adds that HD affects one out of every 10,000 Americans, slowly diminishing the affected individuals ability to walk, think, talk and reason. Founded in 2000, ISB was established to unravel the mysteries of complex biological systems and to identify strategies for predicting and preventing human diseases such as cancer, diabetes and AIDS. The Institute has grown to 14 faculty members and more than 250 staff members; has an annual budget of more than $35 million; and an extensive network of academic and industrial partners. About Complete GenomicsFounded in 2006, Complete Genomics is a California company that has developed a novel approach to sequencing human DNA that is revolutionizing the human genome sequencing industry. Complete Genomics combines its proprietary third-generation DNA sequencing technology with its high-performance computing capabilities to deliver low-cost, high-quality genomic data on an unprecedented scale….Read the Full Story







